0001209191-24-003437.txt : 20240216 0001209191-24-003437.hdr.sgml : 20240216 20240216160012 ACCESSION NUMBER: 0001209191-24-003437 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240214 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: George Jean CENTRAL INDEX KEY: 0001291804 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40499 FILM NUMBER: 24648143 MAIL ADDRESS: STREET 1: CRITICAL THERAPEUTICS INC STREET 2: 60 WESTVIEW STREET CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyteir Therapeutics, Inc. CENTRAL INDEX KEY: 0001662244 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 455429901 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: BUILDING B, SUITE 450 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 857-285-4140 MAIL ADDRESS: STREET 1: 99 HAYDEN AVENUE STREET 2: BUILDING B, SUITE 450 CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-02-14 0 0001662244 Cyteir Therapeutics, Inc. CYT 0001291804 George Jean C/O CYTEIR THERAPEUTICS, INC. 99 HAYDEN AVE, BUILDING B, SUITE 450 LEXINGTON MA 02421 1 0 0 0 0 Common Stock 2024-02-14 4 M 0 14150 1.69 A 14150 D Common Stock 2444265 I See Footnote Stock Option (Right to Buy) 1.69 2024-02-14 4 M 0 14150 0.00 D 2024-02-03 2033-02-03 Common Stock 14150 0 D Shares held by Lightstone Ventures II, L.P. and Lightstone Ventures II (A), L.P. LSV Associates II, LLC is the general partner of Lightstone Ventures II, L.P. and Lightstone Ventures II (A), L.P. The Reporting Person is a managing director of LSV Associates II, LLC. The Reporting Person disclaims beneficial ownership of the securities reported herein, except to the extent of her pecuniary interest therein. /s/ David Gaiero, as attorney-in-fact for Jean George 2024-02-16